These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21054730)

  • 1. Retention of adolescents with substance dependence and coexisting mental health disorders in outpatient alcohol and drug group therapy.
    Pagey B; Deering D; Sellman D
    Int J Ment Health Nurs; 2010 Dec; 19(6):437-44. PubMed ID: 21054730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of young people attending alcohol and other drug treatment services in Aotearoa, New Zealand: clinical file search.
    Schroder R; Sellman D; Frampton C; Deering D
    Aust N Z J Psychiatry; 2008 Nov; 42(11):963-8. PubMed ID: 18941961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment.
    Schroder R; Sellman D; Frampton C; Deering D
    Drug Alcohol Rev; 2009 Nov; 28(6):663-8. PubMed ID: 19930021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing an integrated substance use and mental health service in the specialised setting of a youth detention centre.
    Stathis SL; Letters P; Doolan I; Whittingham D
    Drug Alcohol Rev; 2006 Mar; 25(2):149-55. PubMed ID: 16627304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs.
    Wittchen HU; Behrendt S; Höfler M; Perkonigg A; Rehm J; Lieb R; Beesdo K
    Drug Alcohol Depend; 2009 Jun; 102(1-3):151-7. PubMed ID: 19362792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dropping out of outpatient psychiatric treatment: a preliminary report of a 2-year follow-up of 1500 psychiatric outpatients in Kermanshah, Iran.
    Khazaie H; Rezaie L; de Jong DM
    Gen Hosp Psychiatry; 2013; 35(3):314-9. PubMed ID: 23265950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group intervention for coexisting psychosis and substance use disorders in rural Australia: outcomes over 3 years.
    Bradley AC; Baker A; Lewin TJ
    Aust N Z J Psychiatry; 2007 Jun; 41(6):501-8. PubMed ID: 17508320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of relapse to substance use in comorbid adolescents.
    Ramo DE; Anderson KG; Tate SR; Brown SA
    Addict Behav; 2005 Oct; 30(9):1811-23. PubMed ID: 16139961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use and treatment seeking in young offenders on community orders.
    Lennings CJ; Kenny DT; Nelson P
    J Subst Abuse Treat; 2006 Dec; 31(4):425-32. PubMed ID: 17084797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are cannabis users who participate in a randomized clinical trial different from other treatment seekers?
    Frewen AR; Baillie AJ; Montebello ME
    J Subst Abuse Treat; 2009 Apr; 36(3):339-44. PubMed ID: 18834692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse prevalence and comorbidity with other psychiatric disorders among adolescents with severe emotional disturbances.
    Greenbaum PE; Prange ME; Friedman RM; Silver SE
    J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):575-83. PubMed ID: 1890091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matching adolescents with a cannabis use disorder to multidimensional family therapy or cognitive behavioral therapy: treatment effect moderators in a randomized controlled trial.
    Hendriks V; van der Schee E; Blanken P
    Drug Alcohol Depend; 2012 Sep; 125(1-2):119-26. PubMed ID: 22560728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.
    Arendt M; Munk-Jørgensen P
    Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent cigarette smoking and mental health symptoms.
    Chang G; Sherritt L; Knight JR
    J Adolesc Health; 2005 Jun; 36(6):517-22. PubMed ID: 15901517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.